Skip to content

Avanos Medical AVNS Market capitalization

Market capitalization at other companies

Stryker logo
StrykerSYK
$125.84B-11.4%
Cardinal Health logo
Cardinal HealthCAH
$49.72B+49.4%
Boston Scientific logo
Boston ScientificBSX
$93.26B-37.5%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$915.07M-20.4%
Medtronic logo
MedtronicMDT
$103.96B-3.8%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$1.05B+9.5%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Enterprise value$1.24B+3.0%
P/S1.6×-0.1×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Computed from the period-end share price: $651.57M.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's market capitalization?
Avanos Medical (AVNS) reported market capitalization of $651.57M in Q1 2026.
How has Avanos Medical's market capitalization changed year-over-year?
Avanos Medical's market capitalization decreased by 1.2% year-over-year, from $659.23M to $651.57M.
What is the long-term trend for Avanos Medical's market capitalization?
Over 5 years (2020 to 2025), Avanos Medical's market capitalization has grown at a -25.1% compound annual growth rate (CAGR), from $2.21B to $521.28M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.